Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002537750 | SCV003636442 | uncertain significance | Inborn genetic diseases | 2022-08-02 | criteria provided, single submitter | clinical testing | The c.1340C>T (p.S447L) alteration is located in exon 7 (coding exon 4) of the HLCS gene. This alteration results from a C to T substitution at nucleotide position 1340, causing the serine (S) at amino acid position 447 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001277484 | SCV001464439 | uncertain significance | Holocarboxylase synthetase deficiency | 2020-08-15 | no assertion criteria provided | clinical testing |